In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils.
Amon
U
U
PsoriSol Centre for Dermatology and Allergy, Hersbruck, Germany. Amon@psorisol.de
Amon
S
S
Gibbs
B F
BF
D001491:Basophils / Q000187:drug effects* / Q000276:immunology; D003876:Dermatitis, Atopic / Q000097:blood / Q000276:immunology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D016593:Terfenadine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*
D004791:Enzyme Inhibitors; D006634:Histamine H1 Antagonists; D007073:Immunoglobulin E; D016593:Terfenadine; C093230:fexofenadine; D011493:Protein Kinase C